Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5322 ARTÍCULOS , VIENDO DEL 2341 AL 2355

Assessing Bone Health and Fracture Risk in Parkinson's Disease: Is Bone Mineral Density Enough?

Ganguly J, Bernaola MT.

Ann Indian Acad Neurol. 2023 Jul-Aug;26(4):361-362. doi: 10.4103/aian.aian_452_23. Epub 2023 Jul 14.

Parkinson's Disease: Diagnostic Challenges Amidst Transdiagnostic and Overlapping Mental Health Symptoms

Madabushi JS, Gupta M, Pearce B, Gupta N.

Cureus. 2023 Mar 25;15(3):e36661. doi: 10.7759/cureus.36661. eCollection 2023 Mar.

Comparing the hippocampal volumetric atrophy between demented and nondemented individuals with Parkinson's disease: A systematic review and meta-analysis

Yazdan Panah M, Mokary Y, Shah S, Thapa S, Chand S, Shaygannejad V, Mirmosayyeb O.

Health Sci Rep. 2023 Sep 11;6(9):e1514. doi: 10.1002/hsr2.1514. eCollection 2023 Sep.

Formation of templated inclusions in a forebrain α-synuclein mouse model is independent of LRRK2

Dues DJ, Ma Y, Nguyen APT, Offerman AV, Beddows I, Moore DJ.

bioRxiv [Preprint]. 2023 Aug 20:2023.08.19.553965. doi: 10.1101/2023.08.19.553965.

GUCY2C signaling limits dopaminergic neuron vulnerability to toxic insults

Cheslow L, Byrne M, Kopenhaver JS, Iacovitti L, Smeyne RJ, Snook AE, Waldman SA.

Res Sq [Preprint]. 2023 Oct 13:rs.3.rs-3416338. doi: 10.21203/rs.3.rs-3416338/v1.

The SATB1-MIR22-GBA axis mediates glucocerebroside accumulation inducing a cellular senescence-like phenotype in dopaminergic neurons

Russo T, Kolisnyk B, Aswathy BS, Wan Kim T, Martin J, Plessis-Belair J, Ni J, Pearson JA, Park EJ, Sher RB, Studer L, Riessland M.

bioRxiv [Preprint]. 2023 Jul 21:2023.07.19.549710. doi: 10.1101/2023.07.19.549710.

3.1 Levodopa infusion for Parkinson's disease

Odin P, Rosqvist K.

In: Odin P, Chaudhuri KR, Aquilonious SM, Mundt-Petersen U, editors. Where are We? Continuous Dopaminergic Stimulation for Parkinson's Disease [Internet]. Berkshire (UK): Empowering Strategic Performance Ltd; 2023 Jan 1.

Device-aided therapies for Parkinson's disease: "All for one, one for all, that is our device"

Hall D.

Parkinsonism Relat Disord. 2023 Nov;116:105862. doi: 10.1016/j.parkreldis.2023.105862. Epub 2023 Sep 19.

Amantadine for NeuroenhaNcement in acutE patients Study - a protocol for a prospective pilot proof of concept phase IIb study in intensive and intermediate care unit patients (ANNES)

Hofmann A, Blum C, Single C, Adeyemi K, Schwarz P, Siokas V, Rattay TW, Häberle HA, Riessen R, Brendel B, Haug I, Bösel R, Zago M, Martus P, Ziemann U, Mengel A, Feil K.

BMC Neurol. 2023 Aug 22;23(1):308. doi: 10.1186/s12883-023-03345-w.

Why the Gut Microbiome Must Be Considered When Evaluating the Impact of Pesticides on Parkinson's Disease Risk

Ré DB, Rideout HJ.

J Parkinsons Dis. 2023;13(7):1077-1078. doi: 10.3233/JPD-239004.

Effects of Amantadine Sulfate on Motor Impairment and Execution of Motor Sequences in Patients With Parkinson Disease

Müller T, Kuhn W.

Clin Neuropharmacol. 2023 Sep-Oct 01;46(5):171-174. doi: 10.1097/WNF.0000000000000566. Epub 2023 Jul 31.

Focused Ultrasound Ablation of the Globus Pallidus Internus for Parkinson's Disease

Schrag A.

N Engl J Med. 2023 Feb 23;388(8):759-760. doi: 10.1056/NEJMe2215506.

"Suboptimal" placement of STN DBS electrodes as a novel strategy in Parkinson's disease?

Schechtmann G, Glud AN, Jourdain VA, Bergholt B, Sørensen JCH.

Acta Neurochir (Wien). 2023 Dec;165(12):3943-3945. doi: 10.1007/s00701-023-05796-z. Epub 2023 Oct 4.

Editorial: Personalized care in neurological diseases

Fernandes JB, Godinho C, Outeiro TF, Baixinho CL.

Front Hum Neurosci. 2023 May 30;17:1216902. doi: 10.3389/fnhum.2023.1216902. eCollection 2023.

Excessive daytime sleepiness in Parkinson's disease: the key is beyond sleep macrostructure

Provini F, Ferri R.

Sleep. 2023 Apr 12;46(4):zsac209. doi: 10.1093/sleep/zsac209.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias